Here are the latest quarterly results of the stocks in the . For more detailed updates, check the latest stock quotes.
Click on title to sort | Jun 2021 | Jun 2022 | YoY %-Change | Get More Info | ||||
---|---|---|---|---|---|---|---|---|
Name | Net Sales (Rs m) |
PAT (Rs m) |
Net Sales (Rs m) |
PAT (Rs m) |
Net Sales (%) |
PAT (%) |
P/E* (x) |
|
AUROBINDO PHARMA | 57,020 | 7,790 | 62,359 | 5,244 | 9.4% | -32.7% | 15.3 | More Info
|
AUROBINDO PHARMA | 57,020 | 7,790 | 62,359 | 5,244 | 9.4% | -32.7% | 15.3 | More Info
|
AUROBINDO PHARMA | 57,020 | 7,790 | 62,359 | 5,244 | 9.4% | -32.7% | 15.3 | More Info
|
AUROBINDO PHARMA | 57,020 | 7,790 | 62,359 | 5,244 | 9.4% | -32.7% | 15.3 | More Info
|
BIOCON | 17,606 | 1,645 | 21,395 | 2,104 | 21.5% | 27.9% | 29.4 | More Info
|
BIOCON | 17,606 | 1,645 | 21,395 | 2,104 | 21.5% | 27.9% | 29.4 | More Info
|
CIPLA | 55,044 | 7,118 | 53,752 | 7,066 | -2.3% | -0.7% | 15.2 | More Info
|
CIPLA | 55,044 | 7,118 | 53,752 | 7,066 | -2.3% | -0.7% | 15.2 | More Info
|
CIPLA | 55,044 | 7,118 | 53,752 | 7,066 | -2.3% | -0.7% | 15.2 | More Info
|
DIVIS LABORATORIES | 19,606 | 5,571 | 22,550 | 7,020 | 15.0% | 26.0% | 53.8 | More Info
|
DIVIS LABORATORIES | 19,606 | 5,571 | 22,550 | 7,020 | 15.0% | 26.0% | 53.8 | More Info
|
GLENMARK PHARMA | 29,649 | 3,065 | 27,773 | 2,111 | -6.3% | -31.1% | N.A. | More Info
|
LUPIN | 42,702 | 5,480 | 37,438 | -868 | -12.3% | -115.8% | 18.4 | More Info
|
LUPIN | 42,702 | 5,480 | 37,438 | -868 | -12.3% | -115.8% | 18.4 | More Info
|
LUPIN | 42,702 | 5,480 | 37,438 | -868 | -12.3% | -115.8% | 18.4 | More Info
|
PIRAMAL ENTERPRISES | 29,087 | 3,685 | 21,613 | 80,062 | -25.7% | 2,072.9% | N.A. | More Info
|
SUN PHARMA | 97,187 | 14,087 | 107,618 | 20,959 | 10.7% | 48.8% | 13.0 | More Info
|
SUN PHARMA | 97,187 | 14,087 | 107,618 | 20,959 | 10.7% | 48.8% | 13.0 | More Info
|
ZYDUS LIFESCIENCES | 40,018 | 6,455 | 39,643 | 5,626 | -0.9% | -12.8% | 11.4 | More Info
|
ZYDUS LIFESCIENCES | 40,018 | 6,455 | 39,643 | 5,626 | -0.9% | -12.8% | 11.4 | More Info
|
Sector Aggregate | 928,887 | 131,218 | 954,805 | 193,156 | 2.8% | 47.2% | ||
* Trailing 12 months earnings, excluding extraordinary / exceptional items. |
Mar 2022 Results | Sep 2022 Results | Latest Quarter Results | View All Results |